Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Parallel trade, GSK and the ECJ: the beauty of equivocation

This article was originally published in SRA

Executive Summary

The European Court of Justice (ECJ) Judgement in the recent GlaxoSmithKline versus Greek wholesalers case smacks of little more than fence-sitting, suggests Edward Miller, Partner at international law firm Reed Smith. “I think the legal arguments that the Court has come up with are slightly different than the ones that have been kicked around before, but I think that the practical consequence of it is that it is going to change very little,” Mr Miller told EURALex.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS108482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel